日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Effects of adding urinary alkalizer citrate mixture to febuxostat in gout patients with combined-type hyperuricemia and low urine pH: a prospective cohort study

在伴有混合型高尿酸血症和低尿pH值的痛风患者中，添加尿液碱化剂柠檬酸盐混合物与非布司他联合治疗的效果：一项前瞻性队列研究

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-026-03768-z
Guo, Kai; Li, Changgui; Terkeltaub, Robert; Dalbeth, Nicola; Wang, Xuefeng; Ji, Xiaopeng; Chen, Ying; Cui, Lingling; Liu, Zhen; Li, Xinde; He, Yuwei; Lu, Jie; Sun, Wenyan; Han, Lin; Zhang, Hui; Ji, Aichang; Sun, Mingshu; Wang, Can
痛风
代谢
发表日期：2026
文献求助 收藏

Particle uptake by macrophages triggers bifurcated transcriptional pathways that differentially regulate inflammation and lysosomal gene expression.

巨噬细胞对颗粒的摄取会触发分叉的转录通路，从而差异性地调节炎症和溶酶体基因表达

期刊:Immunity
影响因子:26.3
doi:10.1016/j.immuni.2025.02.023
Cobo Isidoro, Murillo-Saich Jessica, Alishala Mohnish, Calderon Stephen, Coras Roxana, Hemming Benjamin, Inkum Faith, Rosas Fiorella, Takei Riku, Spann Nathan, Prohaska Thomas A, Alabarse Paulo V G, Jeong Se-Jin, Nickl Christian K, Cheng Anyan, Li Benjamin, Vogel Andrea, Weichhart Thomas, Fuster José J, Le Thomas, Bradstreet Tara R, Webber Ashlee M, Edelson Brian T, Razani Babak, Ebert Benjamin L, Taneja Reshma, Terkeltaub Robert, Bryan Ru Liu, Guma Monica, Glass Christopher K
细胞生物学
巨噬细胞
炎症
发表日期：2025
文献求助 收藏

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease

痛风合并肾病患者血清尿酸达标情况与慢性肾脏病进展的关系

期刊:Jama Internal Medicine
影响因子:23.3
doi:10.1001/jamainternmed.2024.6212
Wang, Yilun; Dalbeth, Nicola; Terkeltaub, Robert; Zhang, Yuqing; Li, Xiaoxiao; Zeng, Chao; Lei, Guanghua; Wei, Jie
痛风
代谢
发表日期：2025
文献求助 收藏

Gut bacteria degrade purines via the 2,8-dioxopurine pathway

肠道细菌通过2,8-二氧嘌呤途径降解嘌呤。

期刊:Nature Microbiology
影响因子:19.4
doi:10.1038/s41564-025-02079-4
Liu, Yuanyuan; Zhou, Zhiwei; Jarman, J Bryce; Chen, Haoqing; Miranda-Velez, Michelle; Terkeltaub, Robert; Dodd, Dylan
微生物学
发表日期：2025
文献求助 收藏

The Gut Microbiome in Hyperuricemia and Gout

高尿酸血症和痛风中的肠道微生物群

期刊:Arthritis & Rheumatology
影响因子:10.9
doi:10.1002/art.43118
Terkeltaub, Robert; Dodd, Dylan
微生物学
痛风
代谢
发表日期：2025
文献求助 收藏

Systematic literature review on Calcium Pyrophosphate Deposition (CPPD) nomenclature: condition elements and clinical states- A Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus project

关于焦磷酸钙沉积（CPPD）命名法的系统性文献综述：疾病要素和临床状态——痛风、高尿酸血症和晶体相关疾病网络（G-CAN）共识项目

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2024-004847
Jauffret, Charlotte; Adinolfi, Antonella; Sirotti, Silvia; Cirillo, Daniele; Ingrao, Luca; Lucia, Alessandro; Cipolletta, Edoardo; Filippucci, Emilio; Tedeschi, Sara; Terkeltaub, Robert; Dalbeth, Nicola; Pascart, Tristan; Filippou, Georgios
痛风
代谢
发表日期：2025
文献求助 收藏

Impact of adding urine alkalization therapy to xanthine oxidase inhibitor in gout management: a prospective cohort study

在痛风治疗中，尿液碱化疗法联合黄嘌呤氧化酶抑制剂的效果：一项前瞻性队列研究

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/keaf091
Wang, Can; Guo, Kai; Dalbeth, Nicola; Sun, Mingshu; Lu, Jie; Chen, Ying; Zhang, Hui; Wang, Xuefeng; Ji, Xiaopeng; Li, Xinde; Sun, Wenyan; Han, Lin; Cui, Lingling; Liu, Zhen; Ji, Aichang; He, Yuwei; Terkeltaub, Robert; Li, Changgui
痛风
代谢
发表日期：2025
文献求助 收藏

Risk of Hepatotoxicity in Patients With Gout Treated With Febuxostat or Benzbromarone: A Propensity Score-Matched Cohort Study

非布司他或苯溴马隆治疗痛风患者发生肝毒性的风险：一项倾向评分匹配队列研究

期刊:Arthritis Care & Research
影响因子:3.3
doi:10.1002/acr.25547
Sun, Wenyan; Cui, Lingling; Terkeltaub, Robert; Chen, Ying; Li, Xinde; Cheng, Xiaoyu; Liu, Tian; Dalbeth, Nicola; Li, Changgui
痛风
毒理研究
代谢
发表日期：2025
文献求助 收藏

Features Associated With Different Inflammatory Phenotypes of Calcium Pyrophosphate Deposition Disease: A Study Using Data From the International American College of Rheumatology/EULAR Calcium Pyrophosphate Deposition Classification Criteria Cohort

与焦磷酸钙沉积病不同炎症表型相关的特征：一项基于国际美国风湿病学会/欧洲抗风湿病联盟焦磷酸钙沉积分类标准队列数据的研究

期刊:Arthritis & Rheumatology
影响因子:10.9
doi:10.1002/art.42962
Pascart, Tristan; Latourte, Augustin; Tedeschi, Sara K; Dalbeth, Nicola; Neogi, Tuhina; Adinolfi, Antonella; Arad, Uri; Andres, Mariano; Becce, Fabio; Bardin, Thomas; Cipolletta, Edoardo; Ea, Hang-Korng; Filippou, Georgios; Filippucci, Emilio; FitzGerald, John; Iagnocco, Annamaria; Jansen, Tim L; Janssen, Matthijs; Lioté, Frédéric; So, Alexander; McCarthy, Geraldine M; Ramonda, Roberta; Richette, Pascal; Rosenthal, Ann; Scirè, Carlo; Silvagni, Ettore; Sirotti, Silvia; Sivera, Francisca; Stamp, Lisa K; Taylor, William J; Terkeltaub, Robert; Choi, Hyon K; Abhishek, Abhishek
炎症/感染
炎症
发表日期：2024
文献求助 收藏

The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout

COMPARE 是一项头对头、随机对照试验，旨在比较 SEL-212（培加替酶联合雷帕霉素纳米颗粒，ImmTOR™）与培洛替酶治疗难治性痛风的疗效。

期刊:Rheumatology
影响因子:4.4
doi:10.1093/rheumatology/kead333
Baraf, Herbert S B; Khanna, Puja P; Kivitz, Alan J; Strand, Vibeke; Choi, Hyon K; Terkeltaub, Robert; Dalbeth, Nicola; DeHaan, Wesley; Azeem, Rehan; Traber, Peter G; Keenan, Robert T
痛风
mTOR
代谢
OMP
COMP
OMPA
发表日期：2024
文献求助 收藏